Stonepine Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-108,094
Closed -$1.07M 74
2025
Q3
$1.07M Buy
108,094
+78,094
+260% +$813K 0.87% 27
2025
Q2
$298K Buy
+30,000
New +$316K 0.29% 48
2023
Q2
Sell
-416,519
Closed -$4.09M 23
2023
Q1
$4.09M Buy
+416,519
New +$4.45M 1.37% 15

Other funds holding DVAX

Stonepine Capital Management's DVAX Position: Q4 2025 in Review

Stonepine Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 108,094 shares — an estimated $1.07M sold.

Stonepine Capital Management first reported a position in DVAX in Q1 2023 and held it in 3 quarters. The position peaked at $4.09M in Q1 2023. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Stonepine Capital Management reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 108,094 Dynavax Technologies shares in Q4 2025, an estimated $1.07M.
  • Stonepine Capital Management first reported a position in Dynavax Technologies in Q1 2023 and held it in 3 quarters.
  • Stonepine Capital Management's Dynavax Technologies position peaked at $4.09M in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Stonepine Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.